Showing results (691-700 of 5,007) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|April 8, 2006
Colorectal cancer in Hispanics: a population at risk for earlier onset, advanced disease, and decreased survivalDimitrios Stefanidis, Brad H Pollock, Jennifer Miranda, et al.
American Journal of Clinical Oncology|April 8, 2006
Preliminary investigation of symptom distress in the head and neck patient population: validation of a measurement instrumentHeather A Jones, Diane Hershock, Mitchell Machtay, et al.
American Journal of Clinical Oncology|April 8, 2006
The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patientsByung-Joo Lee, Soo-Geun Wang, Jin-Sik Choi, et al.
American Journal of Clinical Oncology|April 8, 2006
Definitive radiotherapy for juvenile nasopharyngeal angiofibromaWilliam J McAfee, Christopher G Morris, Robert J Amdur, et al.
American Journal of Clinical Oncology|April 8, 2006
The incidence of potential interactions between dietary supplements and prescription medications in cancer patients at a Veterans Administration HospitalAlison H Lee, Susan E Ingraham, Monica Kopp, et al.
American Journal of Clinical Oncology|April 8, 2006
Evaluation of nutritional status in cancer patients receiving radiotherapy: a prospective studyDiclehan Unsal, Bulent Mentes, Muge Akmansu, et al.
American Journal of Clinical Oncology|April 8, 2006
New approaches in hormone refractory prostate cancerGuru Sonpavde, Thomas E Hutson
American Journal of Clinical Oncology|February 1, 1990
The treatment of malignant mesothelioma of the pleura: review of a 5-year experience, with special reference to radiotherapyD L Ball, D G Cruickshank
American Journal of Clinical Oncology|October 1, 1990
Phase II study of fludarabine phosphate (NSC 312887) in patients with advanced cervical cancer. A Southwest Oncology Group studyD D Von Hoff, S Green, E A Surwit, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinomaE Tellez-Bernal, M Belehradek, G Recondo, et al.
Pageof 501